Therapeutic potential of liver X receptor beta in depression and anxiety DOI
Xiao-Yu Song, Jan-Åke Gustafsson

Brain medicine :, Год журнала: 2024, Номер unknown, С. 1 - 4

Опубликована: Окт. 4, 2024

Liver X receptors (LXRs), particularly LXRβ, are emerging as crucial players in the translation of basic neuroscience to clinical psychiatry. These nuclear receptor transcription factors, initially known for their roles cholesterol metabolism and inflammation, now revealing promising connections between molecular mechanisms psychiatric symptoms. This review highlights recent breakthroughs understanding LXRβ's regulation function behaviors relevant depression anxiety, derived from studies using animal paradigms that capture specific features these disorders. We explore how preclinical findings shaping our comprehension mood-related at level potentially paving way innovative therapeutic strategies. As a ligand-activated factor, LXRβ represents novel target drug development, bridging gap bench discoveries bedside treatments neuropsychiatric discuss challenges opportunities translating research into interventions, emphasizing potential personalized medicine approaches bench-to-bedside article underscores importance advancing treatment complex mental health conditions, while acknowledging nuanced interpretation required when extrapolating human

Язык: Английский

Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress DOI Creative Commons
Siying Li,

Zaoyi Wang,

Gang Liu

и другие.

Frontiers in Nutrition, Год журнала: 2024, Номер 11

Опубликована: Авг. 1, 2024

Catechins, a class of phytochemicals found in various fruits and tea leaves, have garnered attention for their diverse health-promoting properties, including potential combating neurodegenerative diseases. Among these catechins, (-)-epigallocatechin-3-gallate (EGCG), the most abundant polyphenol green tea, has emerged as promising therapeutic agent due to its potent antioxidant anti-inflammatory effects. Chronic neuroinflammation oxidative stress are key pathological mechanisms diseases such Alzheimer's disease (AD) Parkinson's (PD). EGCG neuroprotective efficacy scavenging free radicals, reducing attenuating neuroinflammatory processes. This review discusses molecular EGCG's anti-oxidative chronic neuroinflammation, emphasizing effects on autoimmune responses, neuroimmune system interactions, focusing related AD PD. By elucidating action impact processes, this underscores intervention AD, PD, possibly other Overall, emerges natural compound stress, offering novel avenues strategies treatment disorders.

Язык: Английский

Процитировано

9

Mechanisms of comorbidity between Alzheimer's disease and pain DOI Creative Commons
Kaifang Yao, Shenjun Wang, Zhifang Xu

и другие.

Alzheimer s & Dementia, Год журнала: 2025, Номер 21(2)

Опубликована: Фев. 1, 2025

ABSTRACT Clinical studies have revealed a significant correlation between pain and neurodegenerative diseases, particularly Alzheimer's disease (AD). However, due to cognitive speech impairments, AD patients, especially those in moderate severe stages, are often overlooked management. The challenges obtaining pain‐related information from this population exacerbate the issue. Although recent clinical research has increasingly recognized comorbidity of pain, pathological alterations interactive mechanisms underlying relationship remain inadequately explored. This review provides comprehensive analysis features with without comorbidity. It examines processes, including neuroinflammation, peripheral‐central immune interactions, neurotransmitter dynamics. Furthermore, it highlights current assessment management strategies patients. By offering theoretical framework, aims support development effective approaches serve as reference for interventions targeting AD‐associated pain. Highlights CP encompasses multiple interrelated biological pathways, such neurodegeneration inflammatory responses. damage neurons synapses patients influences brain regions responsible processing thereby reducing response. Neuroinflammation plays vital role both CP. Enhanced responses an impact on CNS promote sensitization. Common exist CP, influencing cognition, emotion, perception.

Язык: Английский

Процитировано

1

Identification of Potential Intervention Targets Involved in Prior Exercise that Attenuates Peripheral Neuropathic Pain by Integrating Transcriptome and Whole-genome Bisulfite Sequencing Analyses DOI
Binglin Chen, Ting Wang,

Chenchen Zhu

и другие.

Molecular Neurobiology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 17, 2025

Язык: Английский

Процитировано

0

CD8+T cell infiltration-associated barrier function of brain endothelial cells is enhanced by Astragalus polysaccharides via inhibiting PI3K/AKT signaling pathway DOI
Yan Zhao,

Qijin Lu,

Jinyun Ma

и другие.

Journal of Leukocyte Biology, Год журнала: 2024, Номер 117(1)

Опубликована: Сен. 3, 2024

Pathogenic CD8+T cells play an essential role in neuroinflammation and neural injury, which leads to the progression of inflammatory neurological disorders. Thus, blocking infiltration is necessary for treatment neuroinflammatory diseases. Our previous study demonstrated that astragalus polysaccharide (APS) could significantly reduce experimental autoimmune encephalomyelitis mice. However, mechanism by APS suppresses cell remains elusive. In this study, we further found lipopolysaccharide (LPS)-induced model. Furthermore, established mouse brain endothelial (bEnd.3) injury model interleukin-1β or LPS vitro. The results showed downregulated expression vascular adhesion molecule1 decrease bEnd.3 cells. also upregulated zonula occludens-1 cadherin transendothelial migration PI3K/AKT signaling pathway might mediate protective effect on against injury. addition, integrity LPS-induced summary, our indicate can peripheral via enhancing barrier function cells; it may be a potential prevention

Язык: Английский

Процитировано

1

Hippocampal cannabinoid type 2 receptor alleviates chronic neuropathic pain‐induced cognitive impairment via microglial DUSP6 pathway in rats DOI
Lichi Xu, Afang Zhu, Shuxiang Xu

и другие.

The FASEB Journal, Год журнала: 2024, Номер 38(21)

Опубликована: Ноя. 5, 2024

Abstract Approximately 50% of patients with chronic neuropathic pain experience cognitive impairment, which negatively impacts their quality life. The cannabinoid type 2 receptor (CB2R) may be involved in hippocampal processes. However, its role pain‐induced impairment remains elusive. Spared nerve injury (SNI) was used to induce rats, while the novel‐object recognition test and Y‐maze were employed assess function. Immunofluorescence, western blotting, stereotaxic microinjection utilized elucidate potential mechanisms. We observed a reduction mechanical threshold SNI rats. This accompanied by tendency for microglia adopt pro‐inflammatory functions. Notably, no changes detected CB2R expression. downregulation endogenous ligands AEA 2‐AG evident. Hippocampal agonist mitigated correlated anti‐inflammatory Additionally, SNI‐induced activation p‐ERK/NFκB pathway hippocampus. Activation reversed this process upregulating DUSP6 expression microglia. effects elicited could inhibited through microglial via adeno‐associated virus (AAV) microinjection. Conversely, overexpression using AAV ameliorated deficits remained unaffected administration antagonist. Our findings demonstrate that can mitigate modulation DUSP6/ERK/NFκB pathway.

Язык: Английский

Процитировано

1

Therapeutic potential of liver X receptor beta in depression and anxiety DOI
Xiao-Yu Song, Jan-Åke Gustafsson

Brain medicine :, Год журнала: 2024, Номер unknown, С. 1 - 4

Опубликована: Окт. 4, 2024

Liver X receptors (LXRs), particularly LXRβ, are emerging as crucial players in the translation of basic neuroscience to clinical psychiatry. These nuclear receptor transcription factors, initially known for their roles cholesterol metabolism and inflammation, now revealing promising connections between molecular mechanisms psychiatric symptoms. This review highlights recent breakthroughs understanding LXRβ's regulation function behaviors relevant depression anxiety, derived from studies using animal paradigms that capture specific features these disorders. We explore how preclinical findings shaping our comprehension mood-related at level potentially paving way innovative therapeutic strategies. As a ligand-activated factor, LXRβ represents novel target drug development, bridging gap bench discoveries bedside treatments neuropsychiatric discuss challenges opportunities translating research into interventions, emphasizing potential personalized medicine approaches bench-to-bedside article underscores importance advancing treatment complex mental health conditions, while acknowledging nuanced interpretation required when extrapolating human

Язык: Английский

Процитировано

0